tiprankstipranks
Eagle Pharmaceuticals (EGRX)
:EGRX
US Market
Holding EGRX?
Track your performance easily

Eagle Pharmaceuticals (EGRX) Stock Price & Analysis

209 Followers

EGRX Stock Chart & Stats


Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

EGRX FAQ

What was Eagle Pharmaceuticals’s price range in the past 12 months?
Eagle Pharmaceuticals lowest stock price was <$0.01 and its highest was $6.81 in the past 12 months.
    What is Eagle Pharmaceuticals’s market cap?
    Eagle Pharmaceuticals’s market cap is $8.31M.
      When is Eagle Pharmaceuticals’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Eagle Pharmaceuticals’s earnings last quarter?
      Currently, no data Available
      Is Eagle Pharmaceuticals overvalued?
      According to Wall Street analysts Eagle Pharmaceuticals’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Eagle Pharmaceuticals pay dividends?
        Eagle Pharmaceuticals does not currently pay dividends.
        What is Eagle Pharmaceuticals’s EPS estimate?
        Eagle Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Eagle Pharmaceuticals have?
        Eagle Pharmaceuticals has 12,986,971 shares outstanding.
          What happened to Eagle Pharmaceuticals’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Eagle Pharmaceuticals?
          Currently, no hedge funds are holding shares in EGRX
          ---

          Company Description

          Eagle Pharmaceuticals

          Eagle Pharmaceuticals, Inc. engages in the provision of injectable products. Its products include argatroban, ryanodex, docetaxel injection, non-alcohol formulation and bendeka. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.
          ---

          EGRX Earnings Call

          Q2 2023
          0:00 / 0:00
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Catalyst Pharma
          Durect
          Medicinova
          Trevena
          Protagonist Therapeutics
          Entera Bio
          Popular Stocks
          ---
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis